Showing posts with label Nihon Kohden Corporation. Show all posts
Showing posts with label Nihon Kohden Corporation. Show all posts

Wednesday 2 January 2019

Non-invasive Brain Trauma Monitoring Devices Market Expected To Trigger A Revenue Increase To USD 15.12 Billion By 2024:Key Participant Philips Healthcare, GE Healthcare


San Francisco, 03 January, Non-invasive Brain Trauma Monitoring Devices Market Analysis By Product (Monitoring Devices, Consumables), By End-use (Hospital, Neurological Centers), And Segment Forecasts To 2024.

The global non-invasivebrain trauma monitoring devices market is expected to reach USD 15.12 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.
Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.
The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry’s growth.
The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.
Access Full Research Report On Non-invasive Brain Trauma Monitoring Devices Market Analysis:
www.grandviewresearch.com/industry-analysis/non-invasive-brain-trauma-monitoring-devices-market

Further key findings from the study suggest:
·         Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 60.0% in 2015. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
·         The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products. 
·         The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 75.0% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth. 
·         On the contrary, neurological centers are expected to grow at a sturdy rate over the forecast period. The availability of specialized staff and advanced methodologies are likely to boost the demand for this segment. 
·         North America dominated the non-invasive brain trauma monitoring devices market in 2015. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period. 
·         Some key players operating in this industry include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Advanced Brain Monitoring, CAS Medical Systems, Inc., Siemens, Compumedics Ltd., Medtronic Plc., and Integra LifeSciences. New product launches, co-developments, and acquisitions are the key initiatives in this industry. 
·         For instance, in January 2013, Natus Medical acquired Astro-Med’s products included in monitoring and neurodiagnostic products. This acquisition helped the company to widen the portfolio of EEG systems.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global non-invasive brain trauma monitoring devices market on the basis of products, end-use, and region:
Global Non-invasive Brain Trauma Monitoring Devices Market By Product (USD Million), 2013 - 2024
·         Monitoring Devices
o    Intracranial Pressure Monitors
o    MRI
o    CT Scanner
o    PET Scanner
o    EEG
o    MEG
o    Other
·         Consumables
o    Hospital
o    Neurological Centers
o    Others
Global Non-invasive Brain Trauma Monitoring Devices Market By End-use (USD Million), 2013 - 2024
·         Hospital
·         Neurological Centers
·         Others
Non-invasive Brain Trauma Monitoring Devices Market By Region (USD Million), 2013 - 2024
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Argentina
·         MEA
o    South Africa
o    Saudi Arabia
Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Thursday 6 December 2018

Cell Surface Marker Detection Market Expected To Trigger A Revenue Increase To USD 6.49 Billion By 2022:Key Participant MSiemens Healthcare, Nihon Kohden Corporation


San Francisco, 06 December 2018, The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 
Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 
Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 
Access Full Research Report On Cell Surface Marker Detection Market Analysis:
www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market

Further key findings from the report suggest:
·         Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 
·         Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 
·         Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 
·         North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 
·         North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 
·         Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 
·         Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 
·         These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions 
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell surface marker detection market on the basis of product, application, and region:
Cell Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         Flow Cytometry
·         Hematology Analyzers
·         Reagents & Kits
Cell Surface Marker Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         Disease Diagnosis & Identification
·         Research & Drug Discovery
·         Others
Cell Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         North America
·         Europe
·         Asia Pacific
·         RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/